echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > J Gastroenterology: calcium-channel blockers may improve postoperative prognosis in patients with intrahepatic cholangiocarcinoma

    J Gastroenterology: calcium-channel blockers may improve postoperative prognosis in patients with intrahepatic cholangiocarcinoma

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer, with a high incidence in East and Southeast Asia and rising


    The researchers retrospectively evaluated clinical data


    The results showed that in both the original and matched cohorts, the total lifetime and recurrence-free survival (OS) of the CCBs group were significantly longer than those of the OS in the non-CCBs group (98 months vs 45 months, p = 0.


    This study confirms that CCB can improve disease prognosis after resection in ICC patients, and the mechanism may be related to CCB not only acting directly on cancer cells, but also affecting these related


    Original Source:

    Kenichiro Kodama.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.